We are live on ! Find out more
MED icon

Medifast

277 hedge funds and large institutions have $1.05B invested in Medifast in 2022 Q4 according to their latest regulatory filings, with 48 funds opening new positions, 99 increasing their positions, 89 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

55% more first-time investments, than exits

New positions opened: 48 | Existing positions closed: 31

11% more repeat investments, than reductions

Existing positions increased: 99 | Existing positions reduced: 89

5% more funds holding

Funds holding: 263 → 277 (+14)

3.42% less ownership

Funds ownership: 86.35% → 82.93% (-3.4%)

11% less capital inflows, than outflows

Capital inflows: $90.1M | Capital outflows: $101M

13% less call options, than puts

Call options by funds: $10.8M | Put options by funds: $12.4M

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
277
Holders Change
+14
Holders Change %
+5.32%
% of All Funds
4.44%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
48
Increased
99
Reduced
89
Closed
31
Calls
$10.8​M
Puts
$12.4​M
Net Calls
-⁠$1.66​M
Net Calls Change
+$26​K

MED Hedge Fund Activity: Q4 2022 in Review

277 of the 6,245 institutional investors tracked by Wall St. Rank reported a position in Medifast (MED) for Q4 2022, worth a combined $1.05B — up 1.4% from $1.03B a quarter earlier.

Buyers outnumbered sellers: 48 funds opened new MED positions and 31 closed out — a net gain of 17 holders — while 99 added to existing stakes and 89 trimmed.

The largest buyer was Vanguard Group, adding an estimated $11.4M. The largest seller was BlackRock, cutting an estimated $17.7M.

  • 277 institutional investors held Medifast (MED) as of Q4 2022, up from 263 in Q3 2022.
  • Funds reported $1.05B of Medifast stock for Q4 2022, up 1.4% quarter-over-quarter.
  • 48 funds opened new Medifast positions in Q4 2022 and 31 closed out, a net change of +17 holders.
  • The largest Medifast buyer in Q4 2022 was Vanguard Group, an estimated $11.4M added.
  • The largest Medifast seller in Q4 2022 was BlackRock, an estimated $17.7M sold.

Based on aggregated 13F filings for Q4 2022.